Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Interim Effectiveness of 2025–2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States
Saved in:
| Published in: | Infectious Diseases and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868938387262537728 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Infectious Diseases and Therapy |
| description | |
| discipline_display | Communicable Diseases, Epidemiology |
| discipline_facet | Communicable Diseases, Epidemiology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:95643 |
| institution | FRELIP |
| journal_source_facet | Infectious Diseases and Therapy |
| last_indexed | 2026-06-25T03:35:38.811Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Interim Effectiveness of 2025–2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| subject_facet | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| title | Interim Effectiveness of 2025–2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States |
| title_alt | Efectividad provisional de las vacunas contra la COVID-19 mRNA-1283 y BNT162b2 2025-2026 contra resultados relacionados con COVID-19 en adultos ≥ 65 años en Estados Unidos Efficacité intermédiaire des vaccins COVID-19 mRNA-1283 et BNT162b2 2025-2026 contre les issues liées au COVID-19 chez les adultes de 65 ans et plus aux États-Unis Efetividade Interina das Vacinas mRNA-1283 e BNT162b2 COVID-19 para 2025–2026 Contra Desfechos Relacionados à COVID-19 em Adultos com Idade ≥ 65 Anos nos Estados Unidos |
| title_auth | Interim Effectiveness of 2025–2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States |
| title_es_txt | Efectividad provisional de las vacunas contra la COVID-19 mRNA-1283 y BNT162b2 2025-2026 contra resultados relacionados con COVID-19 en adultos ≥ 65 años en Estados Unidos |
| title_fr_txt | Efficacité intermédiaire des vaccins COVID-19 mRNA-1283 et BNT162b2 2025-2026 contre les issues liées au COVID-19 chez les adultes de 65 ans et plus aux États-Unis |
| title_full | Interim Effectiveness of 2025–2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States |
| title_fullStr | Interim Effectiveness of 2025–2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States |
| title_full_unstemmed | Interim Effectiveness of 2025–2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States |
| title_pt_txt | Efetividade Interina das Vacinas mRNA-1283 e BNT162b2 COVID-19 para 2025–2026 Contra Desfechos Relacionados à COVID-19 em Adultos com Idade ≥ 65 Anos nos Estados Unidos |
| title_short | Interim Effectiveness of 2025–2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States |
| title_sort | interim effectiveness of 2025–2026 mrna-1283 and bnt162b2 covid-19 vaccines against covid-19-related outcomes among adults aged ≥ 65 years in the united states |
| topic | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| url | https://link.springer.com/article/10.1007/s40121-026-01395-4 |